TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan.

Meisenberg, Cornelia; Ward, Simon E; Schmid, Peter; El-Khamisy, Sherif F

Meisenberg, Cornelia; Ward, Simon E; Schmid, Peter; El-Khamisy, Sherif F.

Afiliación

Meisenberg C; The Wellcome Trust DNA Repair Group, Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK.
Ward SE; The Sussex Translational Drug Discovery Group, University of Sussex, Brighton, UK.
Schmid P; Brighton and Sussex Medical School, University of Sussex, Brighton, UK (former affiliation) ; Centre of Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University London, UK.
El-Khamisy SF; The Wellcome Trust DNA Repair Group, Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK ; Krebs Institute, Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield S10 2TN, UK ; Center of Genomics, Helmy Institute for Medical Sciences, Zewail

J Cancer Sci Ther ; 6(7): 258-267, 2014 Jul 25.

Article en En | MEDLINE | ID: mdl-25232464

Palabras clave

Enzymatic assay; Small cell lung cancer; TDP1 protein level; TOP1-DNA; Topotecan

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: J Cancer Sci Ther Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google